Wikidata

(Q63842855)

English

A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)

clinical trial

In more languages

Statements

title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Croatia
0 references
France
0 references
Germany
0 references
Japan
0 references
Lithuania
0 references
Mexico
0 references
Netherlands
0 references
New Zealand
0 references
Poland
0 references
Portugal
0 references
Spain
0 references
Taiwan
0 references
United Kingdom
0 references
start time
6 August 2012
0 references
end time
17 March 2015
0 references
number of participants
878
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63842855&oldid=2006979983"